Gumieniczek, A.; Berecka-Rycerz, A.; Hubicka, U.; Żmudzki, P.; Lejwoda, K.; Kozyra, P.
Photodegradation of the H1 Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity. Pharmaceutics 2020, 12, 560.
https://doi.org/10.3390/pharmaceutics12060560
AMA Style
Gumieniczek A, Berecka-Rycerz A, Hubicka U, Żmudzki P, Lejwoda K, Kozyra P.
Photodegradation of the H1 Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity. Pharmaceutics. 2020; 12(6):560.
https://doi.org/10.3390/pharmaceutics12060560
Chicago/Turabian Style
Gumieniczek, Anna, Anna Berecka-Rycerz, Urszula Hubicka, Paweł Żmudzki, Karolina Lejwoda, and Paweł Kozyra.
2020. "Photodegradation of the H1 Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity" Pharmaceutics 12, no. 6: 560.
https://doi.org/10.3390/pharmaceutics12060560
APA Style
Gumieniczek, A., Berecka-Rycerz, A., Hubicka, U., Żmudzki, P., Lejwoda, K., & Kozyra, P.
(2020). Photodegradation of the H1 Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity. Pharmaceutics, 12(6), 560.
https://doi.org/10.3390/pharmaceutics12060560